Screener
Kyverna Therapeutics, Inc. KYTX Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Kyverna Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219397
FAQ
- What is Kyverna Therapeutics, Inc.'s return on invested capital?
- Kyverna Therapeutics, Inc. (KYTX) reported return on invested capital of -94.5% in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s return on invested capital changed year-over-year?
- Kyverna Therapeutics, Inc.'s return on invested capital increased by 5.1% year-over-year, from -99.6% to -94.5%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Kyverna Therapeutics, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude